Real-world patient characteristics and clinical outcomes in patients with myelofibrosis in Japan
Yusuke Yasutomi, Masashi Takano, Yi-Chen Chen, Chi-Chang Chen, Seok-Won Kim, Catherine McGuiness, Alex Slowley, Keita Kirito · 2026
Read Real-world patient characteristics and clinical outcomes in patients with myelofibrosis in Japan by Yusuke Yasutomi, Masashi Takano, Yi-Chen Chen, Chi-Chang Chen, Seok-Won Kim, Catherine McGuiness, Alex Slowley, Keita Kirito (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0348598.txt.
Description
Yusuke Yasutomi and co-workers describe real-world care for myelofibrosis, a bone marrow disease, in Japan using a large hospital records database. Anemia drives much of the illness burden in this disease. Their 2026 study follows more than eight hundred patients, including a group treated with the first targeted drug approved in Japan for the condition.
Most patients were in their early seventies, and about six in ten had anemia at the start. More than a third already depended on blood transfusions. In the drug-treated group, treatment lasted a little over a year on typical doses. Survival figures differed between the full group and the treated group. Such records help planners see the true cost and course of care.
Catalog record
| CREATOR | Yusuke Yasutomi, Masashi Takano, Yi-Chen Chen, Chi-Chang Chen, Seok-Won Kim, Catherine McGuiness, Alex Slowley, Keita Kirito |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38276 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |